MCM
ANAC

Manchester Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Manchester Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,581
Closed -$244K – 1122
2014
Q4 		$244K Hold
7,581
– – 0.03% 316
2014
Q3 		$186K Hold
7,581
– – 0.02% 362
2014
Q2 		$134K Hold
7,581
– – 0.02% 491
2014
Q1 		$152K Buy
+7,581
New +$147K 0.02% 412

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Manchester Capital Management's ANAC Position: Q1 2015 in Review

Manchester Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2015, closing a stake of 7,581 shares — an estimated $244K sold.

Manchester Capital Management first reported a position in ANAC in Q1 2014 and held it in 4 quarters. The position peaked at $244K in Q4 2014. 157 funds tracked by Wall St. Rank hold ANAC as of Q1 2015.

  • Manchester Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2015 after selling out during the quarter.
  • Manchester Capital Management sold 7,581 ANACOR PHARMACEUTICALS INC COM shares in Q1 2015, an estimated $244K.
  • Manchester Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 4 quarters.
  • Manchester Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $244K in Q4 2014.
  • 157 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2015.

Based on Manchester Capital Management's 13F filing for Q1 2015, filed 7 May 2015.